Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Assets (2016 - 2025)

Historic Assets for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $5.3 million.

  • International Stem Cell's Assets rose 196.91% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 196.91%. This contributed to the annual value of $5.2 million for FY2024, which is 402.6% down from last year.
  • As of Q3 2025, International Stem Cell's Assets stood at $5.3 million, which was up 196.91% from $5.5 million recorded in Q2 2025.
  • Over the past 5 years, International Stem Cell's Assets peaked at $6.0 million during Q1 2021, and registered a low of $4.9 million during Q3 2021.
  • Over the past 5 years, International Stem Cell's median Assets value was $5.4 million (recorded in 2023), while the average stood at $5.4 million.
  • Its Assets has fluctuated over the past 5 years, first plummeted by 1727.85% in 2021, then skyrocketed by 1188.02% in 2023.
  • International Stem Cell's Assets (Quarter) stood at $4.9 million in 2021, then increased by 3.82% to $5.1 million in 2022, then grew by 4.97% to $5.4 million in 2023, then fell by 4.03% to $5.2 million in 2024, then increased by 2.11% to $5.3 million in 2025.
  • Its Assets stands at $5.3 million for Q3 2025, versus $5.5 million for Q2 2025 and $5.6 million for Q1 2025.